Previous close | 137.90 |
Open | 137.90 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 137.90 - 137.90 |
52-week range | 113.55 - 150.80 |
Volume | |
Avg. volume | 4 |
Market cap | 16.104B |
Beta (5Y monthly) | 0.89 |
PE ratio (TTM) | 11.69 |
EPS (TTM) | 11.80 |
Earnings date | 24 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Quest Diagnostics (NYSE: DGX), a leader in diagnostic information services, and PathAI, a global provider of artificial intelligence-powered technology for pathology, today announced a multi-faceted collaboration designed to accelerate the adoption of digital and AI pathology innovations to improve quality, speed and efficiency in diagnosing cancer and other diseases.
A week ago, Quest Diagnostics Incorporated ( NYSE:DGX ) came out with a strong set of first-quarter numbers that could...
Let's talk about the popular Quest Diagnostics Incorporated ( NYSE:DGX ). The company's shares saw a decent share price...